- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04322071
Family Factors in Young People With Diabetes: a Qualitative Study
Factors Affecting Diabetes Self-management in Young People and Their Families: a Qualitative Study
Study Overview
Detailed Description
Family is an important factor in the self-management of type 1 diabetes by children and young people. Existing research has explored the experience of living with diabetes, considered from the perspective of children and parents, but has not provided children's diabetes teams with the information they need to support young people with higher blood glucose levels, and therefore higher risks of long term complications related to their diabetes.
During this qualitative study the researcher will meet with young people (aged 12-15yrs) and their families for a joint interview, held in the family home, exploring the factors which they consider important in diabetes self-management.
One interview will be held with each family. Recruitment of 8 families is planned.
The interviews will be recorded and transcribed to allow thematic analysis, allowing identification of common factors considered to be important by families.
The HbA1c of young people with diabetes is checked regularly in clinic and provides an assessment of blood glucose levels over the preceding months. Higher HbA1c levels are associated with higher risk of long term complications.
The index young people will be recruited in 2 groups: one group will have lower risk of long term complications (identified by an HbA1c level of <58mmol/mol). The other will have higher risk (HbA1c 75-100mmol/mol). A comparison will be made between the families in each group, to identify which themes are more common in the lower or higher risk groups.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Kent
-
Ashford, Kent, United Kingdom, TN24 0LZ
- East Kent Hospitals University Foundation NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 12 - 15 years (between their 12th and 16th birthday at recruitment)
- Type 1 diabetes diagnosed for at least 6 months
- Group 1: HbA1c <58mmols/mol on last known test
- Group 2: HbA1c ≥75mmols/mol and <100mmols/mol on last known test
- Willing to participate in group interview with at least one parent/carer
Exclusion Criteria:
- Family currently identified as not suitable for lone visits
- Participants with inadequate English to take part in a semi-structured interview conducted in English
- Children and Young people for whom the last HbA1c incongruent with their previous results will be excluded
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Lower risk of long term complications
Young people with diabetes who have HbA1c <58mmols/mol, and family members.
|
Qualitative interviews only
|
|
Higher risk of long term complications
Young people with diabetes who have HbA1c ≥75mmols/mol and <100mmols/mol, and family members.
|
Qualitative interviews only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thematic Analysis
Time Frame: Interviews of up to 90mins conducted during the study period (a period of 5 weeks ending on the 31st of March 2020)
|
Themes identified against the primary question: what factors do families identify as important in self-management of a young person's Type 1 diabetes
|
Interviews of up to 90mins conducted during the study period (a period of 5 weeks ending on the 31st of March 2020)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Anitha Kumaran, MBBS, PhD, University of Southampton
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 52030
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Lund UniversityEnrolling by invitationType 1 Diabetes Mellitus | Stage 2 Type 1 Diabetes | Stage 1 Type 1 Diabetes | Stage 3 Type 1 DiabetesSweden
-
Immunocore LtdNot yet recruitingType 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...RecruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes MellitusIraq, Pakistan
-
GentiBio, IncRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes (T1D)United States
-
Stanford UniversityUniversity College Dublin; The Leona M. and Harry B. Helmsley Charitable TrustNot yet recruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM) | Exercise Physiology | Type 1 Diabetes MellitisUnited States
-
Dasman Diabetes InstituteRecruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM)Kuwait
-
Superior UniversityActive, not recruitingType 2 Diabetes Mellitus 1Pakistan
-
Insulet CorporationNot yet recruitingType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes (DM)New Zealand
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
Clinical Trials on Interview
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaboratorsCompleted
-
Centro Hospitalar Lisboa NorteUniversity of Lisbon; Faculdade de Psicologia e de Ciências de Educação da...Unknown
-
Mayo ClinicNot yet recruitingSpontaneous Coronary Artery DissectionUnited States
-
Ohio UniversityNew York Blood CenterCompleted
-
University of New MexicoCompletedPregnancy TerminationUnited States
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute, FranceCompletedCancer | Elderly | Ethnographic Interview | Social Representation of Being Aged | Reasons of Non-participation in Clinical Trials | Qualitative MethodFrance
-
Wayne State UniversityBlue Cross Blue Shield of Michigan FoundationCompleted
-
Beth Israel Deaconess Medical CenterCompletedDyspepsia | Heartburn | Gastroesophageal Reflux Disease (GERD)United States
-
University of ExeterUniversity of Nottingham; University of Bristol; National Institute for Health...Completed
-
Sakarya UniversityActive, not recruitingNursing Education | Mental Disorder | Stigma of Mental Illness | Implicit Association TestTurkey